Clinical Trial Update: Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports safety outcomes and pharmacokinetic data (skin and plasma concentrations) for a dermal formulation of azithromycin tested in Phase 1/2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Disease

Drugs mentioned

• Azithromycin (dermal formulation) (azithromycin)

Snippet

Sponsor: University of Zurich | Conditions: Lyme Disease | Phase 1, Phase 2 | Status: COMPLETED